Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy.
Chouaib
Salem
S
INSERM U487, Institut Fédératif de Recherches 54, Institut Gustave Roussy, Villejuif, France. chouaib@igr.fr
D019496:Cancer Vaccines / Q000276:immunology*; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D019496:Cancer Vaccines